Qing Jiang Selected Research

Mechanistic Target of Rapamycin Complex 1

1/2021	Network Pharmacology-Based Strategy for the Investigation of the Anti-Osteoporosis Effects and Underlying Mechanism of Zhuangguguanjie Formulation.
1/2019	Inactivation of Lkb1 in postnatal chondrocytes leads to epiphyseal growth-plate abnormalities and promotes enchondroma-like formation.
9/2012	Tumor necrosis factor-alpha (TNF-α)-mediated in vitro human retinal pigment epithelial (RPE) cell migration mainly requires Akt/mTOR complex 1 (mTORC1), but not mTOR complex 2 (mTORC2) signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qing Jiang Research Topics

Disease

47	Neoplasms (Cancer) 01/2022 - 12/2004
33	Osteoarthritis 12/2022 - 01/2006
26	Inflammation (Inflammations) 12/2022 - 11/2002
25	Venous Thrombosis (Deep-Vein Thrombosis) 07/2019 - 02/2011
14	Knee Osteoarthritis 05/2022 - 01/2006
12	Infections 01/2021 - 06/2009
11	Pain (Aches) 12/2022 - 11/2003
10	Osteoporosis 08/2022 - 01/2015
9	Thrombosis (Thrombus) 01/2020 - 06/2010
7	Carcinogenesis 01/2021 - 01/2007
6	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 12/2004
6	Hepatocellular Carcinoma (Hepatoma) 06/2018 - 11/2003
5	Wounds and Injuries (Trauma) 05/2022 - 07/2006
5	Type 2 Diabetes Mellitus (MODY) 02/2021 - 10/2017
5	Venous Thromboembolism 01/2021 - 01/2014
5	Asthma (Bronchial Asthma) 01/2018 - 10/2007
4	Osteolysis 02/2022 - 10/2014
4	Congenital Abnormalities (Deformity) 01/2022 - 02/2015
4	Hypersensitivity (Allergy) 07/2021 - 08/2002
4	Colitis 01/2021 - 12/2013
4	Hemorrhage 01/2021 - 07/2017
4	Bone Fractures (Bone Fracture) 07/2019 - 06/2009
4	Scoliosis 01/2019 - 10/2015
3	Postmenopausal Osteoporosis 08/2022 - 04/2018
3	Obesity 01/2022 - 01/2016
3	Chronic Disease (Chronic Diseases) 01/2022 - 07/2014
3	Rupture 03/2021 - 10/2016
3	Fibrosis (Cirrhosis) 01/2021 - 01/2019
3	Bone Resorption 01/2021 - 10/2014
3	Allergic Rhinitis 01/2021 - 06/2009
3	Fever (Fevers) 04/2020 - 04/2013
3	Neoplasm Metastasis (Metastasis) 12/2019 - 06/2016
3	Chondrosarcoma 02/2019 - 12/2014
3	Breast Neoplasms (Breast Cancer) 01/2017 - 12/2012
3	Hemolysis 04/2016 - 07/2014
3	Hypertension (High Blood Pressure) 01/2016 - 07/2006
2	Edema (Dropsy) 12/2022 - 01/2019
2	Stress Fractures (Stress Fracture) 01/2022 - 02/2015
2	Hypertrophy 01/2022 - 12/2014

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2002
14	Vitamin E FDA LinkGeneric 01/2021 - 12/2002
11	CytokinesIBA 02/2022 - 06/2012
11	Pharmaceutical PreparationsIBA 01/2022 - 11/2010
11	gamma-TocopherolIBA 01/2021 - 12/2002
10	Biomarkers (Surrogate Marker)IBA 12/2021 - 05/2003
9	Tocopherols (Tocopherol)IBA 01/2021 - 11/2002
8	Therapeutic UsesIBA 01/2022 - 10/2007
7	EnzymesIBA 12/2022 - 12/2014
6	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2022 - 08/2013
6	LipidsIBA 01/2022 - 04/2013
6	AntioxidantsIBA 12/2020 - 10/2006
6	Peptides (Polypeptides)IBA 10/2019 - 06/2016
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2002
5	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2022 - 01/2011
5	TocotrienolsIBA 01/2022 - 07/2014
5	EicosanoidsIBA 01/2022 - 05/2003
5	SphingolipidsIBA 01/2019 - 12/2004
4	AllergensIBA 04/2021 - 10/2007
4	Phosphotransferases (Kinase)IBA 01/2021 - 01/2007
4	LeptinIBA 01/2021 - 10/2010
4	LigandsIBA 12/2019 - 08/2015
4	PolymersIBA 01/2017 - 04/2013
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2022 - 12/2008
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022 - 01/2016
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2021 - 05/2003
3	Biological ProductsIBA 04/2021 - 05/2012
3	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 01/2019
3	GoldIBA 01/2021 - 02/2016
3	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 09/2012
3	fibrin fragment D (D-dimer)IBA 04/2020 - 07/2013
3	IntegrinsIBA 12/2019 - 01/2019
3	Fluorescent Dyes (Fluorescent Probes)IBA 10/2019 - 12/2013
3	plastochromanol 8IBA 01/2017 - 02/2012
3	MicellesIBA 01/2015 - 03/2014
3	Aspartic Acid (Aspartate)FDA Link 02/2011 - 01/2006
3	CarrageenanIBA 11/2009 - 05/2003
3	alpha-Tocopherol FDA Link 12/2004 - 05/2003
2	Alendronate (Alendronate Sodium)FDA LinkGeneric 08/2022 - 01/2015
2	Capsules (Microcapsules)IBA 05/2022 - 04/2014
2	CholesterolIBA 01/2022 - 03/2017
2	Nucleic AcidsIBA 01/2022 - 01/2017
2	LeukotrienesIBA 01/2022 - 01/2011
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 11/2017
2	TitaniumIBA 01/2022 - 10/2014

Therapy/Procedure

28	Therapeutics 12/2022 - 12/2004
13	Knee Replacement Arthroplasty (Total Knee Replacement) 05/2022 - 02/2008
13	Arthroplasty 01/2020 - 06/2009
10	Hip Replacement Arthroplasty (Total Hip Replacement) 03/2016 - 11/2008
8	Orthopedic Procedures 02/2022 - 01/2013
6	Drug Therapy (Chemotherapy) 01/2021 - 02/2016
6	Blood Transfusion (Blood Transfusions) 01/2020 - 10/2006
4	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 06/2021 - 07/2006
4	Meniscectomy 03/2021 - 02/2015
4	Intra-Articular Injections 01/2021 - 12/2007
4	Stents 06/2020 - 06/2010
4	Microbubbles 01/2017 - 01/2013
3	Prostheses and Implants (Prosthesis) 02/2022 - 06/2009
3	Sutures (Suture) 01/2021 - 02/2006
3	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 10/2020 - 05/2018
3	Immunotherapy 01/2019 - 12/2017